^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture.

^f Tested in combination with heparin sodium (Riker) 1000 units/L.

^g Preservative free.

^h Tested in dextrose 5% in sodium chloride 0.225%.

ⁱ Final concentration after mixing.

^j Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^k Tested in combination with hydrocortisone sodium succinate (Upjohn) 100 mg/L

^l Test performed using the Cubicin formulation.

^m Ceftolozane component. Ceftolozane sulfate in a 2:1 fixed-ratio concentration with tazobactam sodium.

ⁿ Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^o Test performed using the formulation WITH edetate disodium.

^p Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^q Salt not specified.

^r Tested with dopamine HCl (DCC) 3.2 mg/mL.

^s Tested with nitroglycerin (LY) 0.4 mg/mL.

^t Tested with sodium nitroprusside (ES) 0.4 mg/mL.

^u Tested with dobutamine HCl (LI) 4 mg/mL.